LXGTF.US Registered Plan Private Investments Inc
- Market cap
- USD 378.00
- P/E
- -
- P/B
- 15.83x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2024.
Is LXGTF.US undervalued?
Graham numberThe Graham number of Registered Plan Private Investments Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Registered Plan Private Investments Inc fundamental analysis
No fundamental analysis for Registered Plan Private Investments Inc yet.
Registered Plan Private Investments Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Registered Plan Private Investments Inc
Registered Plan Private Investments Inc. operates as a private investment platform company. Its platform allows investors to use their registered plans, including registered retirement savings plans, registered education savings plans, tax-free savings accounts, registered retirement income funds, and registered disability savings plans at their direction to invest in private companies. The company was formerly known as Lexington Biosciences, Inc. and changed its name to Reg…
Full company profileRegistered Plan Private Investments Inc financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
Registered Plan Private Investments Inc annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - |
| Gross Profit | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - |
| Operating Income | 530K | -1.99M | -2.34M | -534K | -460K | -313K | -173K | -158K | -146K |
| EBITDA | -3.60M | -1.99M | -2.34M | -534K | -21.12 | -11.61 | -2.49 | -168.00 | - |
| Net Income | -3.60M | -1.99M | -2.34M | -1.27M | -480.00 | -324K | -175.00 | -177K | -157K |
| EPS | -1.21 | -0.64 | -0.62 | -0.34 | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| Balance Sheet | |||||||||
| Total Assets | 1.04M | 1.43M | 107K | 12.8K | 27.6K | 664.00 | - | - | - |
| Total Liabilities | 209K | 254K | 683K | 1.05M | 1.52M | 1.82M | 811K | 989K | 1.11M |
| Shareholders' Equity | 834K | 1.17M | -575K | -1.04M | -1.49M | -1.82M | -811K | -989K | -1.11M |
| Cash & Short-term Investments | 929K | 1.43M | 107K | 12.8K | 27.6K | 664.00 | - | - | - |
| Total Debt | 19.5K | - | 271K | 843K | - | - | - | - | - |
| Cash Flow | |||||||||
| Operating Cash Flow | -373K | -1.67M | -1.62M | -210K | -325K | -27.0K | -664.00 | - | - |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -373K | -1.67M | -1.62M | -210K | -325K | -27.0K | -664.00 | - | - |
| Ratios | |||||||||
| ROE | -431.2% | -169.9% | - | - | - | - | - | - | - |
| ROA | -344.9% | -139.6% | -2,180.1% | -9,901.6% | -1.7% | -48,831.2% | - | - | - |
| Debt to Equity | 0.02x | - | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Debt to Equity
- Total debt divided by shareholders' equity.
Registered Plan Private Investments Inc dividends
Registered Plan Private Investments Inc has not paid dividends in the last 8 fiscal years.
Last stock split: 1:10 on Apr 26, 2019.
Who owns Registered Plan Private Investments Inc
Ownership data of Registered Plan Private Investments Inc is not available yet.
Registered Plan Private Investments Inc company profile
- Company name
- Registered Plan Private Investments Inc
- Ticker
- LXGTF.US
- ISIN
- CA5290204067
- Exchange
- USA Stocks
- Sector
- Financial Services
- Industry
- Capital Markets
- Fiscal year end
- December
- Address
- 1055 West Hastings Street, Vancouver, BC, Canada, V6E 2E9
- Phone
- 800 320 2640
- Website
- lexingtonbiosciences.com
About Registered Plan Private Investments Inc
Registered Plan Private Investments Inc. operates as a private investment platform company. Its platform allows investors to use their registered plans, including registered retirement savings plans, registered education savings plans, tax-free savings accounts, registered retirement income funds, and registered disability savings plans at their direction to invest in private companies. The company was formerly known as Lexington Biosciences, Inc. and changed its name to Registered Plan Private Investments Inc. in May 2020. The company was incorporated in 2016 and is headquartered in Vancouver, Canada.
Registered Plan Private Investments Inc management
3- Mr. Nicholas John Furber C.A., C.F.A., CPAChief Financial Officer · born 1974
- Mr. Donald Arthur McInnes BAChief Executive Officer · born 1964
- Dr. Jonathan S. MaltzChief Scientific Advisor